[1] Harrison SA, Taub R, Neff GW, et al. Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med, 2023,29(11):2919-2928. [2] Jang H, Kim Y, Lee DH, et al. Outcomes of various classes of oral antidiabetic drugs on nonalcoholic fatty liver disease. JAMA Intern Med,2024,184(4):375-383. [3] Wattacheril JJ, Abdelmalek MF, Lim JK, et al. AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review. Gastroenterology,2023,165(4):1080-1088. [4] Li S, Wang Z, Ding Z, et al. Accelerated four-dimensional free-breathing whole-liver water-fat magnetic resonance imaging with deep dictionary learning and chemical shift modeling. Quant Imaging Med Surg,2024,14(4):2884-2903. [5] Rossi GMC, Mackowiak ALC, Açikgöz BC, et al. SPARCQ: A new approach for fat fraction mapping using asymmetries in the phase-cycled balanced SSFP signal profile. Magn Reson Med,2023,90(6):2348-2361. [6] Li G, Xu Z, Wang Y, et al. Association of serum ferritin with marrow iron concentration using a three-dimension fat analysis & calculation technique sequence in postmenopausal women. J Comput Assist Tomogr,2022,46(3):464-469. [7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪肝专家委员会.非酒精性脂肪性肝病防治指南(2018年版). 实用肝脏病杂志,2018,21(2):177-186. [8] Isaacs S. Nonalcoholic fatty liver disease. Endocrinol Metab Clin North Am,2023,52(1):149-164. [9] Bedogni G, Palmese F, Foschi FG. Nonalcoholic fatty liver disease: an update. Curr Opin Lipidol, 2023,34(3):114-118. [10] 王磊,瞿欢佳,杨文君,等.基于MRI的非酒精性脂肪性肝病患者铁沉积的代谢研究.中华肝脏病杂志, 2023, 31(11):1204-1208. [11] 黄珊珊,顾天伟,方达,等.肥胖人群甘油三酯-葡萄糖指数与非酒精性脂肪性肝炎的关联性研究.中华糖尿病杂志, 2024, 16(9):980-987. [12] 赵亚楠,方明,徐绍岩,等.多声学技术参数联合血清学指标对非酒精性脂肪性肝病肝脂肪变性阶段的诊断价值.中华医学超声杂志电子版, 2023, 20(11):1164-1173. [13] Tsujita Y, Sofue K, Ueshima E, et al. Clinical application of quantitative MR imaging in nonalcoholic fatty liver disease. Magn Reson Med Sci, 2023,22(4):435-445. [14] Virarkar M, Szklaruk J, Jensen CT, et al. What's new in hepatic steatosis. Semin Ultrasound CT MR,2021,42(4):405-415. [15] Tan CH, Al-Kalifah N, Lee WJ, et al. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis. Asian J Surg, 2019,42 (1):203-208. [16] 刘天柱,杨艳红,黄乐生, 等.磁共振IDEAL-IQ序列定量分析 非酒精性脂肪性胰腺疾病糖脂代谢的研究.中华生物医学工程杂志,2019,25(5):605-609. [17] 欧南,魏梅,王劲,彭正伟.应用MRI多回波水脂分离技术评估非酒精性脂肪性肝病患者肝脏脂肪含量效能研究.实用肝脏病杂志,2021,24(4):508-511. [18] 周冷潇,张卿,高鹰,等.成人血脂异常与非酒精性脂肪性肝病 发病风险的前瞻性队列研究.中华全科医师杂志,2024,23(8): 831-838. [19] 王慧,汤展,常文娟,等.非肥胖型与肥胖型非酒精性脂肪性肝 病患者代谢特征和肝脂肪变程度比较.实用肝脏病杂志,2022, 25(5):669-672. [20] 马晨曦,许静,王艳秋. 超声声衰减系数联合血清ALT/AST比值评估非酒精性脂肪性肝病患者肝脂肪变程度价值研究. 实用肝脏病杂志,2025,28(3):374-377. |